ConCallIQ

CIE Automotive India vs JG Chemicals Q3 FY26

Side-by-side earnings comparison across financial stats, AI summaries, management guidance, risks, quotes, and accountability signals.

CIE Automotive India

bullish high

CIE Automotive India reported consolidated Q4 CY25 revenue of INR 23.3 billion, up 15% YoY, driven by strong India operations (INR 15.44 billion, +12% YoY) and Europe (INR 7.88 billion, +21% YoY, but only +4% in euro terms).

Read CIE Automotive India analysis →

JG Chemicals

bullish high

JG Chemicals delivered its highest-ever quarterly revenue of ₹249 crore (up 19% YoY), EBITDA of ₹26 crore, and PAT of ₹18 crore, driven by strong tire industry demand post-GST rate cuts, improved product mix, and higher capacity utilization.

Read JG Chemicals analysis →

Result Snapshot

Revenue₹2,393 Cr₹249 Cr
PAT₹204 Cr₹18 Cr
EBITDA Margin14%10.44%
Sentimentbullishbullish

AI Summary

CIE Automotive India

Q3 FY26 · Manufacturing

CIE Automotive India reported consolidated Q4 CY25 revenue of INR 23.3 billion, up 15% YoY, driven by strong India operations (INR 15.44 billion, +12% YoY) and Europe (INR 7.88 billion, +21% YoY, but only +4% in euro terms). India EBITDA margin was 16.8%, impacted by one-off gratuity costs and energy tariff hikes; adjusted margin stood at 17.9%. Europe EBITDA margin fell to 12.7% due to restructuring costs, but adjusted above 15%. Management highlighted a steady improvement in India growth trajectory (7%, 9%, 12% in last three quarters) and expects this to continue, supported by new order wins of INR 8.7 billion per year in India and capacity expansions across verticals. Key risks include European market weakness, Chinese competition, and slower-than-expected EV adoption. The company is transferring some European capacity to India to leverage cost advantages and trade deals.

Guidance read
India growth trajectory to continue improving: Management expects the quarterly growth trend (7%, 9%, 12%) to sustain, with arithmetic progression likely. Capacity expansions across multiple verticals: Expansions underway in composites, stampings, aluminum, and iron foundry; new export program SOP in June 2026. Transfer of European capacity to India: Moving fully automated presses and gear production cells from Europe to India starting April 2026. Capex to be higher than CY25: Capex in CY26 will exceed CY25 levels, driven by India growth projects.
Risk read
Key risks include European market weakness and Chinese competition — European light vehicle production stagnant; Chinese OEMs gaining share, posing risk to CIE's European business.; Slower EV adoption in Europe — Legasp plant bet on EV components; if EV growth delays further, additional restructuring may be needed.; Aluminium and magnetics restructuring — These verticals underperformed due to customer concentration and CNG bike drop; recovery expected only by H2 CY26.; Underperformance vs industry growth — India Q4 growth of 12% lagged industry; management attributes to CNG and aluminium recognition changes, but gap remains material..
Promise ledger
Scorecard data is being built as historical quarters are processed.

JG Chemicals

Q3 FY26 · Manufacturing

JG Chemicals delivered its highest-ever quarterly revenue of ₹249 crore (up 19% YoY), EBITDA of ₹26 crore, and PAT of ₹18 crore, driven by strong tire industry demand post-GST rate cuts, improved product mix, and higher capacity utilization. The company is executing a greenfield expansion in Gujarat (Phase I capex ~₹45-50 crore, revenue potential ~₹400 crore) expected to commission in Q2 FY27, alongside a brownfield expansion at Naidupa. Management targets doubling revenue every 3-4 years and improving EBITDA margins to 13-14% over 2-3 years via operating leverage and non-rubber mix shift to 70:30. A pilot recycled rubber project shows encouraging initial results. Key risk: zinc price volatility could impact working capital, though management expects inventory gains to flow in Q4.

Guidance read
Gujarat greenfield plant commissioning in H1 FY27: Phase I of the Gujarat plant (40,000 MTPA capacity) expected to commission in Q2 FY27, with full utilization in 2-2.5 years. Revenue target of ₹900-950 crore for FY26: Based on 9M run rate of ~₹700 crore, management expects FY26 revenue to exceed ₹900 crore, potentially reaching ₹950 crore. EBITDA margin expansion to 13-14% in 2-3 years: Core EBITDA margin of 10.5-11% expected to improve to 13-14% through operating leverage and higher specialty product mix. Non-rubber revenue mix target of 30% in 2-3 years: Management targets increasing non-rubber contribution from current 15-17% to 30% over the next 2-3 years.
Risk read
Key risks include Zinc price volatility impacting working capital — Rising zinc prices may increase working capital requirements; management believes internal cash flows are sufficient but risk remains if prices spike sharply.; Slower ramp-up of new Gujarat plant — Commissioning in Q2 FY27 with full utilization expected in 2-2.5 years; any delays or slower customer uptake could impact revenue growth.; Duty removal on zinc dross not yet implemented — Budget removed import duty on zinc scrap but not on zinc dross, a key raw material; management is lobbying for correction, but uncertainty remains.; Zinc sulfate demand sensitivity to farmer pricing — High zinc and sulfuric acid prices are causing farmers to defer purchases, leading to slower offtake; recovery depends on price stabilization..
Promise ledger
Scorecard data is being built as historical quarters are processed.

Key Numbers

CIE Automotive India

Q3 FY26 · Manufacturing
New order wins (India) INR 8.7B
+8.7B YoY

New business won in CY25 for India operations, per year.

New order wins (Europe) INR 2.1B
+2.1B YoY

New business won in CY25 for European operations, per year.

India quarterly sales growth trend 12%
+12pp YoY

Q4 CY25 India sales growth; prior quarters: 7%, 9%.

EV share of new orders (India) 10%
flat

10% of new India orders in CY25 were for EVs, 90% ICE.

JG Chemicals

Q3 FY26 · Manufacturing
Capacity Utilization ~80%
+5pp YoY

Utilization in late 70s of achievable capacity; target 80-85% for efficient operations.

Non-Rubber Revenue Mix 15-17%
+5pp YoY

Non-rubber segment (pharma, ceramics, specialty chemicals) increased from 10% to ~15-17%.

Export Share 13-14%
flat YoY

Exports remain in 10-15% range; management does not expect near-term increase to 25-30%.

Volume Growth (Zinc Oxide) Double-digit
+10%+ YoY

Zinc oxide volumes grew double-digit YoY in 9M FY26; exact figures not disclosed.

Management Guidance

CIE Automotive India

Q3 FY26 · Manufacturing
G

India growth trajectory to continue improving

Management expects the quarterly growth trend (7%, 9%, 12%) to sustain, with arithmetic progression likely.

Management guidance growth
G

Capacity expansions across multiple verticals

Expansions underway in composites, stampings, aluminum, and iron foundry; new export program SOP in June 2026.

Management guidance expansion
G

Transfer of European capacity to India

Moving fully automated presses and gear production cells from Europe to India starting April 2026.

Management guidance expansion
G

Capex to be higher than CY25

Capex in CY26 will exceed CY25 levels, driven by India growth projects.

Management guidance capex

JG Chemicals

Q3 FY26 · Manufacturing
G

Gujarat greenfield plant commissioning in H1 FY27

Phase I of the Gujarat plant (40,000 MTPA capacity) expected to commission in Q2 FY27, with full utilization in 2-2.5 years.

Management guidance expansion
G

Revenue target of ₹900-950 crore for FY26

Based on 9M run rate of ~₹700 crore, management expects FY26 revenue to exceed ₹900 crore, potentially reaching ₹950 crore.

Management guidance revenue
G

EBITDA margin expansion to 13-14% in 2-3 years

Core EBITDA margin of 10.5-11% expected to improve to 13-14% through operating leverage and higher specialty product mix.

Management guidance margins
G

Non-rubber revenue mix target of 30% in 2-3 years

Management targets increasing non-rubber contribution from current 15-17% to 30% over the next 2-3 years.

Management guidance growth

Key Risks

CIE Automotive India

Q3 FY26 · Manufacturing
R

European market weakness and Chinese competition

European light vehicle production stagnant; Chinese OEMs gaining share, posing risk to CIE's European business.

high · management_commentary
R

Slower EV adoption in Europe

Legasp plant bet on EV components; if EV growth delays further, additional restructuring may be needed.

medium · management_commentary
R

Aluminium and magnetics restructuring

These verticals underperformed due to customer concentration and CNG bike drop; recovery expected only by H2 CY26.

medium · analyst_question
R

Underperformance vs industry growth

India Q4 growth of 12% lagged industry; management attributes to CNG and aluminium recognition changes, but gap remains material.

medium · data_observation

JG Chemicals

Q3 FY26 · Manufacturing
R

Zinc price volatility impacting working capital

Rising zinc prices may increase working capital requirements; management believes internal cash flows are sufficient but risk remains if prices spike sharply.

medium · analyst_question
R

Slower ramp-up of new Gujarat plant

Commissioning in Q2 FY27 with full utilization expected in 2-2.5 years; any delays or slower customer uptake could impact revenue growth.

medium · management_commentary
R

Duty removal on zinc dross not yet implemented

Budget removed import duty on zinc scrap but not on zinc dross, a key raw material; management is lobbying for correction, but uncertainty remains.

low · management_commentary
R

Zinc sulfate demand sensitivity to farmer pricing

High zinc and sulfuric acid prices are causing farmers to defer purchases, leading to slower offtake; recovery depends on price stabilization.

low · analyst_question

Key Quotes

CIE Automotive India

Q3 FY26 · Manufacturing
We are moving and we are planning to move certain capacity from our European sites to India. We are executing this plan.
Ander Arnesa Alvarez · CEO
Probably is the best time and I think that everybody knows that the automotive industry in India now is having a boom.
Ander Arnesa Alvarez · CEO

JG Chemicals

Q3 FY26 · Manufacturing
We believe in responsible pricing and whether the demand is muted or is in a buoyant stage, the company has very long-standing relationship with our customers wherein any cost pressure on the company is passed on and is absorbed by our customers.
Anil Jun Mala · Managing Director and CEO
Our internal targets are that every 3 to four years max we want to double our revenues.
Anil Jun Mala · Managing Director and CEO